Insider Transactions Reported by 9 Insiders of Apimeds Pharmaceuticals US, Inc.

Symbol
APUS on NYSE
Location
Matawan, NJ

There are no Buy or Sell transactions made by insiders since 15 Feb 2025

Apimeds Pharmaceuticals US, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Inscobee Inc. 10%+ Owner $8,805,900 12 May 2025
Erik C. Emerson Chief Executive Officer, Director $1,312,500 15 Oct 2025
Christopher Kim Chairman and CMO, Director $485,625 15 Oct 2025
CAROL A. O'DONNELL Director 11 Nov 2025
Bennett Weintraub Director 11 Nov 2025
Mark Corrao Chief Financial Officer 04 Mar 2025
Jakap Koo Director 11 Nov 2025
Elona Kogan Director 11 Nov 2025
Hankil Yoon Director 11 Nov 2025

Recent Insider Transactions by Companies or Individuals for Apimeds Pharmaceuticals US, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.